Issue Date | Title | Author(s) |
2023-08-30 | Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML:a randomized, placebo-controlled study by the ALLG. | Loo, S; Roberts, AW; Anstee, NS; Kennedy, GA; He, SZ-X; Schwarer, AP; Enjeti, AK; D'Rozario, J; Marlton, P; Bilmon, I; Taper, JM; Cull, G; Tiley, C; Verner, E; Hahn, U; Hiwase, DK; Iland, HJ; Murphy, NE; Ramanathan, S; Reynolds, J; Ong, DM; Tiong, IS; Wall, M; Murray, M; Rawling, T; Leadbetter, J; Rowley, L; Latimer, M; Yuen, SLS; Ting, SB; Fong, CY; Morris, KL; Bajel, A; Seymour, JF; Levis, MJ; Wei, AH |
2023-12-21 | Protonophoric and mitochondrial uncoupling activity of aryl-carbamate substituted fatty acids. | MacDermott-Opeskin, H; Clarke, C; Wu, X; Roseblade, A; York, E; Pacchini, E; Roy, R; Cranfield, C; Gale, PA; O'Mara, ML; Murray, M; Rawling, T |
2023-01-15 | Inclusion of the in-chain sulfur in 3-thiaCTU increases the efficiency of mitochondrial targeting and cell killing by anticancer aryl-urea fatty acids. | Rahman, MK; Umashankar, B; Choucair, H; Pazderka, C; Bourget, K; Chen, Y; Dunstan, CR; Rawling, T; Murray, M |
2023-09 | An update on inflammation in uveal melanoma. | Liau, S; Wang, JZ; Zagarella, E; Paulus, P; Dang, NHQH; Rawling, T; Murray, M; Zhou, F |
2024-02-19 | The Role of Autophagy in Human Uveal Melanoma and the Development of Potential Disease Biomarkers and Novel Therapeutic Paradigms. | Wang, JZ; Paulus, P; Niu, Y; Zhu, L; Morisseau, C; Rawling, T; Murray, M; Hammock, BD; Zhou, F |